RANI · Rani Therapeutics Holdings, Inc.

Track RANI — free Ask ALVIS about RANI

$0.84 +0.02 (+3.00%) At close · Jul 29

Market Cap

$104.54M

Shares

123.88M

Rani Therapeutics Holdings, Inc. Earnings Call Transcripts

Every quarterly earnings call for Rani Therapeutics Holdings, Inc. (RANI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts

· $ $5.89M '21 Q4 22-03-29 · $1.03M −$8.95M '24 Q4 25-03-31 LATEST ▲42.1% $1.46M −$10.30M '25 Q4 26-03-26

Rani Therapeutics Holdings, Inc. Q4 FY2025 Earnings Call

Confident tone RaniPill platform validation RT114 (oral bispecific GLP-1/GLP-2) clinical progress Chugai partnership

Audio Transcript Slides 8-K10-K

Rani Therapeutics Holdings, Inc. Q4 FY2024 Earnings Call

Audio Transcript Slides 8-K10-K

Rani Therapeutics Holdings, Inc. Q4 FY2023 Earnings Call

Confident tone RT-111 Phase 1 ustekinumab biosimilar results Celltrion partnership and biosimilar supply Obesity market opportunity and pipeline

Results not yet reported

Audio Transcript Slides 8-K10-K

Rani Therapeutics Holdings, Inc. Q4 FY2022 Earnings Call

Results not yet reported

Audio Transcript Slides 8-K10-K

Rani Therapeutics Holdings, Inc. Q4 FY2021 Earnings Call

Audio Transcript Slides 8-K10-K

Showing 1–5 of 5 earnings calls

Key facts CIK 1856725 CUSIP 753018100 13F (30d) 13 filings 12 filers Visit website Investor relations